Evidence map›Paper›PMID 21531719›Full record

ArticleThe Journal of biological chemistry2011

Deimination of human filaggrin-2 promotes its proteolysis by calpain 1.

Chiung-Yueh Hsu, Julie Henry, Anne-Aurélie Raymond, Marie-Claire Méchin, Valérie Pendaries, Dany Nassar, Britta Hansmann, Stéfana Balica, Odile Burlet-Schiltz, Anne-Marie Schmitt and 4 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 81 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Deimination in epidermal barrier and hair formation.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The Discovery and Function of Filaggrin.International journal of molecular sciences · 2022
    Review
  12. Cracking the Skin Barrier: Liquid-Liquid Phase Separation Shines under the Skin.JID innovations : skin science from molecules to population health · 2021
    Review
  13. Article
  14. Update on canine filaggrin: a review.The veterinary quarterly · 2020
    Review
  15. Deimination, Intermediate Filaments and Associated Proteins.International journal of molecular sciences · 2020
    Review
  16. Article
  17. Article
  18. Deimination and Peptidylarginine Deiminases in Skin Physiology and Diseases.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Chiung-Yueh HsuUMR5165 CNRS, F-31059 Toulouse, France.
Julie Henry
Anne-Aurélie Raymond
Marie-Claire Méchin
Valérie Pendaries
Dany Nassar
Britta Hansmann
Stéfana Balica
Odile Burlet-Schiltz
Anne-Marie Schmitt
Hidenari Takahara
Carle Paul
Guy Serre
Michel Simon
Centre National de la Recherche Scientifique · FRIbaraki University · JPInserm · FRUniversité Toulouse III - Paul Sabatier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Filaggrin-2 (FLG2), a member of the S100-fused type protein family, shares numerous features with filaggrin (FLG), a key protein implicated in the epidermal barrier functions. Both display a related structural organization, an identical pattern of expression and localization in human epidermis, and proteolytic processing of a large precursor. Here, we tested whether FLG2 was a substrate of calpain 1, a calcium-dependent protease directly involved in FLG catabolism. In addition, deimination being critical for FLG degradation, we analyzed whether FLG2 deimination interfered with its proteolytic processing. With this aim, we first produced a recombinant form of FLG2 corresponding to subunits B7 to B10 fused to a COOH-terminal His tag. Incubation with calpain 1 in the presence of calcium induced a rapid degradation of the recombinant protein and the production of several peptides, as shown by Coomassie Blue-stained gels and Western blotting with anti-FLG2 or anti-His antibodies. MALDI-TOF mass spectrometry confirmed this result and further evidenced the production of non-immunoreactive smaller peptides. The degradation was not observed when a calpain 1-specific inhibitor was added. The calpain cleavage sites identified by Edman degradation were regularly present in the B-type repeats of FLG2. Moreover, immunohistochemical analysis of normal human skin revealed colocalization of FLG2 and calpain 1 in the upper epidermis. Finally, the FLG2 deiminated by human peptidylarginine deiminases was shown to be more susceptible to calpain 1 than the unmodified protein. Altogether, these data demonstrate that calpain 1 is essential for the proteolytic processing of FLG2 and that deimination accelerates this process.

Indexed as

AnimalsCalciumCalpainEpidermisFilaggrin ProteinsHumansIntermediate Filament ProteinsMiceMice, TransgenicRecombinant ProteinsCalciumCalpainFilaggrin ProteinsFLG2 protein, humanFLG protein, humanIntermediate Filament ProteinsRecombinant Proteins

Identifiers

PMID21531719
PMCPMC3123089
OpenAlexW2042746300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.